Latest California Healthline Stories
Lawyer Fees Draw Scrutiny as Camp Lejeune Claims Stack Up
The Camp Lejeune Justice Act, which became law last year, created a pathway for veterans and their families to pursue damage claims against the government for toxic exposure at the military base. Now, advocates and lawmakers worry high lawyer fees could shortchange those injured.
ER Doctors Vow to Pursue Case Against Envision Despite Bankruptcy
The lawyer for an emergency physicians group says its lawsuit against Envision Healthcare should be allowed to proceed even though the company has filed for Chapter 11 protection.
Can a Fetus Be an Employee? States Are Testing the Boundaries of Personhood After ‘Dobbs’
Laws granting rights to unborn children have spread in the decades since the U.S. and Missouri supreme courts allowed Missouri’s definition of life as beginning at conception to stand. Now, a wrongful death lawsuit involving a workplace accident shows how sprawling those laws — often intended to curb abortion — have become.
KFF Health News' 'What the Health?': Health Programs Are at Risk as Debt Ceiling Cave-In Looms
A warning from the Treasury Department that the U.S. could default on its debt as soon as June 1 has galvanized lawmakers to intervene. But there is still no obvious way to reconcile Republican demands to slash federal spending with President Joe Biden’s demand to raise the debt ceiling and save the spending fight for a later date. Meanwhile, efforts to pass abortion bans in conservative states are starting to stall as some Republicans rebel against the most severe bans. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Alice Miranda Ollstein of Politico join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
Disability Rights Groups Sue to Overturn California’s Physician-Assisted Death Law
Disability rights advocates and two individuals with disabilities sued Tuesday to overturn the state’s physician-assisted death law, arguing it is unconstitutional, violates the Americans with Disabilities Act, and makes it too easy for people with terminal diseases whose deaths aren’t imminent to kill themselves with a doctor’s help.
Presentan demanda para revocar ley de muerte asistida en California
La ley original de California, que permite a los adultos con enfermedades terminales obtener recetas para medicamentos que pongan fin a su vida, se aprobó en 2016.
Listen: Mifepristone Remains Available for Now. What Happens Next?
The Supreme Court on April 21 ruled that the abortion pill mifepristone should remain widely available while the lower courts consider the issue, blocking earlier rulings that banned or restricted access to the drug. KFF Health News’ Julie Rovner joined NPR’s “Weekend All Things Considered” to discuss the complicated case.
KFF Health News' 'What the Health?': Will They or Won’t They (Block the Abortion Pill)?
The Supreme Court is considering the future of the abortion pill mifepristone, after GenBioPro sued the FDA over limitations that effectively block generic production of the drug, a major part of the market. Congress is considering proposals that would impose Medicaid work requirements, crack down on pharmacy benefit managers, and more. And President Joe Biden moved to expand health coverage to young immigrants known as “Dreamers.” Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Mary Agnes Carey to discuss these issues and more.
An Arm and a Leg: A $229,000 Medical Bill Goes to Court
In 2014, Lisa French had spinal surgery. Before the operation, she was told she would have to pay $1,337 in out-of-pocket costs and that her insurance would cover the rest. However, the hospital ended up sending French a bill for $229,000. When she didn’t pay, it sued her. The case went all the way to […]
KFF Health News' 'What the Health?': The Confusing Fate of the Abortion Pill
The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.